FMO5 and asthma: Our findings suggest that NAPDH oxidase inhibition, which reduces intracellular ROS generation, improves ciliary dysfunction and thus extends the potential role of NADPH oxidases (and particularly NOX4) in asthma beyond the described impact of upregulated NOX4 on airway smooth muscle hypercontractility.20